评论
打印
According to UPI, a combination of chemotherapy and antibody medication
UPI消息称在一项新试验中，将化学疗法和抗体药物相结合
extended the lives of people with triple-negative breast cancer by up to 10 months in a new trial.
能延长三阴性乳腺癌患者的寿命长达10个月。
Researchers led by Queen Mary University of London and St. Bartholomew's Hospital found
伦敦大学玛丽皇后学院和圣巴塞洛缪医院的研究人员发现
that the combination helped the body's immune system turn back the aggressive type of breast cancer.
两种疗法相结合可以帮助身体免疫系统阻挡攻击性乳腺癌。
The method also reduced the risk of death or the cancer progressing by up to 40 percent,
这种方法还可以减少死亡风险，或是减少癌症扩散进程40%，
according to the study published Saturday in New England Journal of Medicine and
该研究于周六发表于《新英格兰医学期刊》并
presented at the European Society for Medical Oncology 2018 Congress in Munich, Germany.
在德国慕尼黑欧洲临床肿瘤学会2018年会议上提出。
译文属可可英语原创，未经允许，不得转载。
